Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
Clinical trial NCT01606345 · COMPLETED
Trial details
- NCT number
- NCT01606345
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.